Biotech Blog

BeiGene, Another Beijing Venture In Cancer Therapy

BeiGene (NASDAQ:BGNE) is a midsized Chinese company headquartered in the Cayman Islands. This is an oncology-focused company with two lead candidates, BGB-3111 and BGB-A317 and a number of early stage assets. Lead drug candidate BGB-3111 is targeting Waldenstrom’s...

read more